Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 14 | 2016 | 811 | 0.930 |
Why?
|
| Herpes Zoster | 8 | 2020 | 80 | 0.740 |
Why?
|
| Vascular Calcification | 1 | 2018 | 8 | 0.560 |
Why?
|
| Ankle Brachial Index | 1 | 2018 | 6 | 0.560 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 52 | 0.550 |
Why?
|
| Body Weight | 7 | 2013 | 197 | 0.530 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 79 | 0.530 |
Why?
|
| Risk Assessment | 4 | 2018 | 1047 | 0.460 |
Why?
|
| Cardiovascular Diseases | 2 | 2018 | 520 | 0.450 |
Why?
|
| Continental Population Groups | 4 | 2013 | 255 | 0.400 |
Why?
|
| Child | 21 | 2020 | 2433 | 0.390 |
Why?
|
| Adolescent | 22 | 2020 | 3464 | 0.360 |
Why?
|
| Humans | 37 | 2020 | 16832 | 0.350 |
Why?
|
| Body Height | 3 | 2010 | 54 | 0.350 |
Why?
|
| Female | 33 | 2020 | 12193 | 0.340 |
Why?
|
| Ethnic Groups | 2 | 2011 | 418 | 0.330 |
Why?
|
| Herpes Zoster Vaccine | 4 | 2013 | 60 | 0.330 |
Why?
|
| Birth Certificates | 1 | 2010 | 24 | 0.330 |
Why?
|
| California | 18 | 2013 | 2244 | 0.320 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2010 | 68 | 0.320 |
Why?
|
| Child, Preschool | 14 | 2019 | 1430 | 0.310 |
Why?
|
| Male | 26 | 2020 | 9556 | 0.290 |
Why?
|
| Young Adult | 17 | 2020 | 2456 | 0.280 |
Why?
|
| Overweight | 5 | 2016 | 262 | 0.280 |
Why?
|
| Prevalence | 12 | 2013 | 785 | 0.280 |
Why?
|
| Infant | 9 | 2020 | 1212 | 0.270 |
Why?
|
| Electronic Health Records | 3 | 2020 | 702 | 0.260 |
Why?
|
| Prenatal Care | 2 | 2020 | 123 | 0.250 |
Why?
|
| Vaccination | 5 | 2020 | 725 | 0.250 |
Why?
|
| Adult | 15 | 2020 | 7255 | 0.240 |
Why?
|
| Body Mass Index | 9 | 2013 | 925 | 0.230 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2019 | 158 | 0.230 |
Why?
|
| Chickenpox Vaccine | 4 | 2020 | 91 | 0.220 |
Why?
|
| Preventive Health Services | 2 | 2016 | 142 | 0.210 |
Why?
|
| Kidney Failure, Chronic | 2 | 2018 | 144 | 0.210 |
Why?
|
| Weight Loss | 2 | 2020 | 302 | 0.210 |
Why?
|
| Hypertension | 3 | 2013 | 475 | 0.210 |
Why?
|
| Retrospective Studies | 12 | 2020 | 2463 | 0.200 |
Why?
|
| Weight Reduction Programs | 2 | 2016 | 51 | 0.200 |
Why?
|
| Risk Factors | 9 | 2018 | 3108 | 0.190 |
Why?
|
| Infant, Newborn | 4 | 2019 | 828 | 0.190 |
Why?
|
| Cohort Studies | 12 | 2020 | 2396 | 0.190 |
Why?
|
| Cross-Sectional Studies | 11 | 2013 | 1233 | 0.190 |
Why?
|
| Psoriasis | 2 | 2011 | 9 | 0.170 |
Why?
|
| Hispanic Americans | 3 | 2012 | 350 | 0.160 |
Why?
|
| Papillomavirus Infections | 2 | 2020 | 141 | 0.160 |
Why?
|
| Incidence | 7 | 2020 | 1229 | 0.160 |
Why?
|
| Mumps | 1 | 2020 | 13 | 0.160 |
Why?
|
| Condylomata Acuminata | 1 | 2020 | 16 | 0.160 |
Why?
|
| Clinical Trials as Topic | 2 | 2018 | 114 | 0.150 |
Why?
|
| Chickenpox | 1 | 2020 | 35 | 0.150 |
Why?
|
| Measles | 1 | 2020 | 25 | 0.150 |
Why?
|
| Hepatitis A Virus, Human | 1 | 2019 | 5 | 0.150 |
Why?
|
| Hepatitis A | 1 | 2019 | 11 | 0.150 |
Why?
|
| Hepatitis A Vaccines | 1 | 2019 | 15 | 0.150 |
Why?
|
| Odds Ratio | 4 | 2018 | 569 | 0.140 |
Why?
|
| Papillomavirus Vaccines | 1 | 2020 | 113 | 0.140 |
Why?
|
| African Americans | 2 | 2012 | 394 | 0.140 |
Why?
|
| Hepatitis B Vaccines | 1 | 2018 | 44 | 0.140 |
Why?
|
| Central Venous Catheters | 1 | 2018 | 3 | 0.130 |
Why?
|
| Catheterization, Central Venous | 1 | 2018 | 10 | 0.130 |
Why?
|
| Proteinuria | 1 | 2018 | 24 | 0.130 |
Why?
|
| Renal Dialysis | 1 | 2018 | 57 | 0.130 |
Why?
|
| Biomarkers | 1 | 2018 | 284 | 0.130 |
Why?
|
| Middle Aged | 10 | 2019 | 7515 | 0.120 |
Why?
|
| Antibodies, Viral | 2 | 2020 | 70 | 0.120 |
Why?
|
| Pregnancy | 5 | 2020 | 1555 | 0.120 |
Why?
|
| Preconception Care | 1 | 2016 | 43 | 0.120 |
Why?
|
| Contraceptives, Oral | 2 | 2013 | 22 | 0.120 |
Why?
|
| Dental Care | 1 | 2015 | 15 | 0.120 |
Why?
|
| Datasets as Topic | 1 | 2015 | 17 | 0.120 |
Why?
|
| Socioeconomic Factors | 3 | 2013 | 571 | 0.120 |
Why?
|
| Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2015 | 31 | 0.110 |
Why?
|
| Advisory Committees | 1 | 2016 | 112 | 0.110 |
Why?
|
| Adenoma | 1 | 2016 | 97 | 0.110 |
Why?
|
| Managed Care Programs | 2 | 2013 | 275 | 0.110 |
Why?
|
| Metabolic Syndrome | 2 | 2012 | 59 | 0.110 |
Why?
|
| Venous Thromboembolism | 1 | 2015 | 55 | 0.110 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2015 | 104 | 0.110 |
Why?
|
| United States | 7 | 2019 | 3858 | 0.100 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 202 | 0.100 |
Why?
|
| Prehypertension | 1 | 2013 | 21 | 0.100 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2013 | 18 | 0.100 |
Why?
|
| Prepaid Health Plans | 2 | 2010 | 16 | 0.100 |
Why?
|
| Lower Extremity | 1 | 2013 | 18 | 0.100 |
Why?
|
| Phosphorus | 1 | 2013 | 6 | 0.100 |
Why?
|
| Drug Utilization | 1 | 2013 | 112 | 0.100 |
Why?
|
| Predictive Value of Tests | 2 | 2011 | 325 | 0.100 |
Why?
|
| Aged | 8 | 2018 | 5901 | 0.090 |
Why?
|
| Kidney | 1 | 2013 | 51 | 0.090 |
Why?
|
| Gallstones | 1 | 2012 | 14 | 0.090 |
Why?
|
| Arm Injuries | 1 | 2012 | 4 | 0.090 |
Why?
|
| Leg Injuries | 1 | 2012 | 7 | 0.090 |
Why?
|
| Contraception | 1 | 2012 | 24 | 0.090 |
Why?
|
| Fractures, Bone | 1 | 2013 | 92 | 0.090 |
Why?
|
| Influenza Vaccines | 1 | 2015 | 300 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2015 | 292 | 0.090 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2012 | 5 | 0.090 |
Why?
|
| Musculoskeletal Pain | 1 | 2012 | 26 | 0.090 |
Why?
|
| Censuses | 1 | 2012 | 30 | 0.090 |
Why?
|
| Dyslipidemias | 1 | 2012 | 57 | 0.090 |
Why?
|
| Asian Americans | 1 | 2012 | 146 | 0.080 |
Why?
|
| Lipids | 1 | 2011 | 66 | 0.080 |
Why?
|
| Health Planning | 1 | 2010 | 15 | 0.080 |
Why?
|
| Quality Control | 1 | 2010 | 37 | 0.080 |
Why?
|
| Patient Selection | 1 | 2012 | 175 | 0.080 |
Why?
|
| Pneumococcal Vaccines | 1 | 2011 | 67 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2012 | 155 | 0.080 |
Why?
|
| Catchment Area (Health) | 1 | 2010 | 8 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2010 | 207 | 0.080 |
Why?
|
| Health Surveys | 1 | 2011 | 226 | 0.080 |
Why?
|
| European Continental Ancestry Group | 1 | 2012 | 400 | 0.080 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 635 | 0.080 |
Why?
|
| Gastroesophageal Reflux | 1 | 2010 | 73 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 311 | 0.070 |
Why?
|
| Pregnancy Outcome | 2 | 2020 | 160 | 0.070 |
Why?
|
| Asthma | 1 | 2012 | 375 | 0.070 |
Why?
|
| Health Status | 1 | 2010 | 256 | 0.070 |
Why?
|
| Healthcare Disparities | 1 | 2010 | 213 | 0.070 |
Why?
|
| Mass Screening | 1 | 2013 | 670 | 0.070 |
Why?
|
| Logistic Models | 3 | 2018 | 796 | 0.070 |
Why?
|
| Delivery of Health Care | 1 | 2010 | 374 | 0.060 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2012 | 515 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 677 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2011 | 410 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2015 | 261 | 0.050 |
Why?
|
| Immunocompetence | 2 | 2012 | 10 | 0.040 |
Why?
|
| Comorbidity | 2 | 2013 | 516 | 0.040 |
Why?
|
| Pregnancy Trimesters | 1 | 2020 | 27 | 0.040 |
Why?
|
| Alphapapillomavirus | 1 | 2020 | 13 | 0.040 |
Why?
|
| Northwestern United States | 1 | 2020 | 53 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2013 | 657 | 0.040 |
Why?
|
| Vaccines, Combined | 1 | 2020 | 80 | 0.040 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2020 | 64 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2019 | 42 | 0.040 |
Why?
|
| Sex Factors | 2 | 2012 | 560 | 0.040 |
Why?
|
| Mass Vaccination | 1 | 2019 | 22 | 0.040 |
Why?
|
| Hepatitis B | 1 | 2018 | 43 | 0.030 |
Why?
|
| Age Factors | 2 | 2010 | 814 | 0.030 |
Why?
|
| Time Factors | 1 | 2020 | 989 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 1098 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 1887 | 0.030 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2016 | 10 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2016 | 25 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2016 | 23 | 0.030 |
Why?
|
| DNA | 1 | 2016 | 25 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 41 | 0.030 |
Why?
|
| Fetal Macrosomia | 1 | 2016 | 27 | 0.030 |
Why?
|
| Sigmoidoscopy | 1 | 2016 | 61 | 0.030 |
Why?
|
| Data Accuracy | 1 | 2016 | 26 | 0.030 |
Why?
|
| Feces | 1 | 2016 | 90 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 291 | 0.030 |
Why?
|
| Seasons | 1 | 2015 | 114 | 0.030 |
Why?
|
| Propensity Score | 1 | 2015 | 78 | 0.030 |
Why?
|
| Occult Blood | 1 | 2016 | 161 | 0.030 |
Why?
|
| Quality Assurance, Health Care | 1 | 2015 | 117 | 0.030 |
Why?
|
| Weight Gain | 1 | 2016 | 167 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 317 | 0.030 |
Why?
|
| Outcome Assessment (Health Care) | 1 | 2015 | 199 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 489 | 0.030 |
Why?
|
| Colonoscopy | 1 | 2016 | 261 | 0.030 |
Why?
|
| Anthropometry | 1 | 2013 | 54 | 0.020 |
Why?
|
| Demography | 1 | 2013 | 89 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 120 | 0.020 |
Why?
|
| Social Class | 1 | 2013 | 106 | 0.020 |
Why?
|
| Reference Values | 1 | 2012 | 78 | 0.020 |
Why?
|
| Thinness | 1 | 2012 | 31 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2013 | 157 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2012 | 44 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2012 | 164 | 0.020 |
Why?
|
| Oceanic Ancestry Group | 1 | 2012 | 30 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2012 | 66 | 0.020 |
Why?
|
| Income | 1 | 2012 | 81 | 0.020 |
Why?
|
| Family Characteristics | 1 | 2012 | 69 | 0.020 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2012 | 85 | 0.020 |
Why?
|
| Educational Status | 1 | 2012 | 163 | 0.020 |
Why?
|
| African Continental Ancestry Group | 1 | 2012 | 117 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2011 | 18 | 0.020 |
Why?
|
| Dermatology | 1 | 2011 | 7 | 0.020 |
Why?
|
| Arthritis, Psoriatic | 1 | 2011 | 5 | 0.020 |
Why?
|
| Phototherapy | 1 | 2011 | 23 | 0.020 |
Why?
|
| Data Collection | 1 | 2012 | 223 | 0.020 |
Why?
|
| Adolescent Development | 1 | 2011 | 11 | 0.020 |
Why?
|
| Health Services Research | 1 | 2012 | 180 | 0.020 |
Why?
|
| Age of Onset | 1 | 2011 | 66 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 346 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 110 | 0.020 |
Why?
|
| Pneumococcal Infections | 1 | 2011 | 43 | 0.020 |
Why?
|
| Obesity, Morbid | 1 | 2012 | 122 | 0.020 |
Why?
|
| Poverty | 1 | 2012 | 167 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2011 | 84 | 0.020 |
Why?
|
| Virus Activation | 1 | 2010 | 4 | 0.020 |
Why?
|
| Child Development | 1 | 2011 | 58 | 0.020 |
Why?
|
| Herpesvirus 3, Human | 1 | 2010 | 40 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2012 | 244 | 0.020 |
Why?
|
| Pediatrics | 1 | 2011 | 147 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 1058 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2011 | 382 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 393 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2010 | 995 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2011 | 693 | 0.010 |
Why?
|
Concepts
(201)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(26)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->